MedPath

Naloxone Hydrochloride

NALOXONE HYDROCHLORIDE

Approved
Approval ID

2d53f70f-3c6d-6934-e054-00144ff88e88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 4, 2019

Manufacturers
FDA

Sina Health Inc

DUNS: 047161553

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NALOXONE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70385-2013
Application NumberANDA070256
Product Classification
M
Marketing Category
C73584
G
Generic Name
NALOXONE HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR
Effective DateFebruary 4, 2019
FDA Product Classification

INGREDIENTS (4)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
NALOXONE HYDROCHLORIDEActive
Quantity: 0.4 mg in 1 mL
Code: F850569PQR
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Naloxone Hydrochloride - FDA Drug Approval Details